In addition, BM core biopsies from 34 patients with HCL were studied before and three months after 2-CdA treatment, based on L26 (CD20) and MB2, and a T-lineage antibody, UCHL-1. The gene discussed is MS4A1; the disease is hairy cell leukemia.